Cited by 25Obstructive Sleep Apnea ResearchLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation

The association of nonalcoholic steatohepatitis and obstructive sleep apnea

Open access
Asfari, Mohammad M., Niyazi, Fadi, Lopez, Rocio, Dasarathy, Srinivasan, McCullough, Arthur J.·2017·European Journal of Gastroenterology & Hepatology

Abstract

BACKGROUND AND AIM: The association between obstructive sleep apnea (OSA) and abnormal liver enzymes has been reported in multiple studies. The existing literature regarding the relationship between OSA and nonalcoholic steatohepatitis (NASH) is conflicting. Thus we aimed to determine the relationship between OSA and NASH from a large database. PATIENTS AND METHODS: A cross-sectional study was performed using the 2012 Nationwide Inpatient Sample. We identified adult patients (18-90 years) who had a diagnosis of OSA using the International Classification of Diseases 9th version codes. The control group was comprised of adult individuals with no discharge records of OSA. NASH diagnosis was also identified using the International Classification of Diseases 9th version codes. The association between OSA and NASH was calculated using univariable and multivariable logistic regression. RESULTS: A total of 30 712 524 hospitalizations were included. The OSA group included 1 490 150 patients versus 29 222 374 in the control non-OSA group. The OSA group average age was 61.8±0.07 years (44.2% females) compared with 57.0±0.11 years (60.1% females) in the non-OSA group. NASH prevalence was significantly higher in the OSA group compared with the non-OSA group [2% (95% confidence interval (CI): 1.9, 2.1) vs. 0.65% (95% CI: 0.63, 0.66), P<0.001]. After adjusting for obesity, diabetes, hypertension, dyslipidemia, the metabolic syndrome and Charlson comorbidity index, OSA patients were three times more likely to have NASH [adjusted odds ratio: 3.1 (95% CI: 3.0-3.3), P<0.001]. CONCLUSION: Patients with OSA are three times more likely to have NASH compared with patients without OSA after controlling for other confounders. These data indicate that OSA should be considered as an independent risk factor for developing NASH.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/meg.0000000000000973

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several studies suggest OSA is associated with more advanced MASLD/MASH histology.

    “and several studies suggest OSA is also associated with more advanced MASLD/MASH histology, 64,65”

    From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [64]

    The Results (Multivariable Comparison) find that patients with OSA were more likely to have NASH, supporting an association with the more serious form of fatty liver disease. But the Discussion says this study could not assess whether OSA was associated with NASH severity; its diagnosis-code data do not establish more advanced histology. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Both OSA and PCOS are associated with MASLD.

    “Both OSA and PCOS are associated with MASLD,”

    From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [64]

    The Results (Multivariable Comparison; page unavailable) report an association between OSA and NASH, a form of fatty liver disease. The paper does not address PCOS, and its finding concerns NASH rather than MASLD as a whole. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

1 of the 28 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Asfari, M. M., Niyazi, F., Lopez, R., Dasarathy, S., & McCullough, A. J.
Affiliations
  • Internal Medicine
  • Quantitative Health Sciences, Cleveland Clinic
  • Cleveland Clinic (US)
Corresponding author
Asfari, Mohammad M.
Venue
European Journal of Gastroenterology & Hepatology
Published
2017-12
Volume
29
Issue
12
Pages
1380-1384
ISSN
0954-691X (ISSN-L)
OpenAlex
W2754110647
Cited by
25
References
28
Citations by year
2026: 3 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 6 · 2019: 3
FWCI
1.82
Type
journal article
Language
en
Open access
Locations
  • European Journal of Gastroenterology & Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK061732)
Topics
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
obstructive sleep apnea, nonalcoholic steatohepatitis, metabolic syndrome, obesity, diabetes mellitus, comorbidities, hospitalization data
MeSH terms
Adolescent, Adult, Aged, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Risk Factors, United States, Prevalence, Case-Control Studies, Databases, Factual, Sleep Apnea, Obstructive, Young Adult, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review